ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases (TKI-CPK-1003)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01248429
Recruitment Status : Completed
First Posted : November 25, 2010
Last Update Posted : June 7, 2012
Sponsor:
Information provided by (Responsible Party):
Centre Oscar Lambret

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : February 2011